Is telmisartan suitable for use in patients under 55 years of age?

Telmisartan can be used in patients under the age of 55 under specific circumstances. Telmisartan is an angiotensin II receptor antagonist and belongs to first-line antihypertensive medications, primarily used for the treatment of essential hypertension. Its antihypertensive effect develops gradually but is stable and long-lasting. Besides lowering blood pressure, it also has cardioprotective effects. For patients under age 55 who have mild to moderate hypertension or conditions such as coronary artery disease or myocardial infarction, and who require prevention of ventricular remodeling, telmisartan may be used under a physician's guidance. However, it should be noted that patients allergic to telmisartan or its excipients should not use this medication. It is also contraindicated in pregnant and lactating women. Additionally, if patients are taking other medications—particularly those that interact with telmisartan, such as aliskiren or potassium-containing salt substitutes—they should consult their physician to adjust the treatment regimen. Furthermore, telmisartan may cause some adverse reactions, such as nausea, vomiting, and elevated blood potassium levels; therefore, close monitoring is necessary during treatment.